rss
Br J Ophthalmol 2008;92:182-185 doi:10.1136/bjo.2007.128967
  • Original Article
    • Clinical science

Longitudinal quantification of aqueous flare and cells in Vogt–Koyanagi–Harada disease

  1. W Fang1,2,3,
  2. H Zhou1,2,3,
  3. P Yang1,2,3,
  4. X Huang1,2,3,
  5. L Wang1,2,3,
  6. A Kijlstra2,4
  1. 1
    Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, PR China
  2. 2
    Uveitis Study Center of Sun Yat-sen University and International Uveitis Study Laboratory of Guangdong Province, Guangzhou, PR China
  3. 3
    State Key Laboratory of Ophthalmology of Sun Yat-sen University, Guangzhou, PR China
  4. 4
    Eye Research Institute Maastricht, Department of Ophthalmology, University Hospital Maastricht, Maastricht, The Netherlands
  1. Prof.Dr. P Yang, Zhongshan Ophthalmic Center, Xianlie Road 54, Guangzhou 510060, PR China; peizengyang{at}hotmail.com
  • Accepted 26 September 2007
  • Published Online First 26 October 2007

Abstract

Aims: To quantitatively evaluate the changes of aqueous flare and cells in eyes with Vogt–Koyanagi–Harada (VKH) disease.

Methods: This prospective study included 35 initial-onset VKH patients (70 eyes) and 46 recurrent VKH patients (92 eyes) following immunotherapy. Aqueous flare and cells were quantified using the laser flare-cell meter before treatment, 2 weeks, 1, 3, 6 and 9 months after treatment.

Results: Before treatment, mean aqueous flare (ph/ms) in initial-onset and recurrent VKH eyes were 8.1 (SD 4.1) vs 43.6 (20.7) (p = 0.000). Following treatment, recurrent VKH eyes showed a significantly higher flare value than initial-onset VKH eyes at 2 weeks, 1, 3 and 6 months. Prior to treatment, mean cell counts (cells/0.5 mm3) in initial-onset and recurrent VKH eyes were 2.0 (1.9) vs 39.4 (23.1) (p = 0.000). Following treatment, recurrent VKH eyes showed significantly higher cell counts than initial-onset VKH eyes at 2 weeks, 1 and 3 months.

Conclusions: Our study shows that recurrent VKH patients displayed a more striking and long-lasting breakdown of the BAB and more severe inflammation than initial-onset VKH patients. Our study also indicates that the disruption of BAB lasted longer than aqueous cells either in initial-onset or in recurrent VKH patients.

Footnotes

  • Competing interests: None declared.

  • Funding: This study was supported in part by the Fund for Project of Science and Technology of Guangdong province (2005B60302009), Key Project of Natural Science Foundation (30630064), National supporting project of PR China and “5010” Clinical Project of Sun Yat-sen University.

This Article

  1. Abstract
  2. Full text
  3. PDF
  4. All versions of this article:
    1. bjo.2007.128967v1
    2. 92/2/182 most recent

Responses

  1. Submit a response
  2. No responses published

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.